Filing Details
- Accession Number:
- 0001179110-14-010388
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-13 18:34:49
- Reporting Period:
- 2014-06-12
- Filing Date:
- 2014-06-13
- Accepted Time:
- 2014-06-13 18:34:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1203343 | Dave Wentz | 3838 West Parkway Blvd Salt Lake City UT 84120 | C.e.o. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-12 | 4,081 | $35.47 | 478,036 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-12 | 4,081 | $75.52 | 473,955 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-06-13 | 1,220 | $35.47 | 475,175 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-13 | 1,220 | $75.50 | 473,955 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2014-06-12 | 7,698 | $0.00 | 7,698 | $35.47 |
| Common Stock | Stock-Settled Stock Appreciation Rights | Disposition | 2014-06-13 | 2,302 | $0.00 | 2,302 | $35.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,302 | 2014-04-27 | 2015-10-27 | No | 4 | M | Direct |
| 40,000 | 2014-04-27 | 2015-10-27 | No | 4 | M | Direct |
Footnotes
- The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
- Weighted average price. Price range in multiple transactions was $75.50 to $75.62, inclusive.
Billionaire Hedge Funds
